Aspiriant LLC’s State Street SPDR S&P MIDCAP 400 ETF Trust MDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.99M Sell
3,036
-27
-0.9% -$18.6K 0.05% 117
2026
Q2
$2.15M Hold
3,063
– – 0.05% 111
2026
Q1
$1.89M Sell
3,063
-60
-2% -$38K 0.05% 115
2025
Q4
$1.88M Sell
3,123
-98
-3% -$58.6K 0.05% 116
2025
Q3
$1.92M Hold
3,221
– – 0.06% 104
2025
Q2
$1.82M Hold
3,221
– – 0.06% 107
2025
Q1
$1.72M Hold
3,221
– – 0.06% 103
2024
Q4
$1.83M Hold
3,221
– – 0.07% 101
2024
Q3
$1.84M Sell
3,221
-8
-0.2% -$4.41K 0.07% 98
2024
Q2
$1.73M Buy
3,229
+158
+5% +$85K 0.07% 98
2024
Q1
$1.71M Hold
3,071
– – 0.07% 103
2023
Q4
$1.56M Hold
3,071
– – 0.07% 106
2023
Q3
$1.4M Sell
3,071
-5
-0.2% -$2.4K 0.07% 108
2023
Q2
$1.47M Hold
3,076
– – 0.07% 102
2023
Q1
$1.41M Hold
3,076
– – 0.07% 102
2022
Q4
$1.36M Sell
3,076
-3
-0.1% -$1.33K 0.07% 104
2022
Q3
$1.24M Hold
3,079
– – 0.06% 104
2022
Q2
$1.27M Buy
3,079
+58
+2% +$26.2K 0.06% 105
2022
Q1
$1.48M Hold
3,021
– – 0.08% 104
2021
Q4
$1.56M Buy
3,021
+9
+0.3% +$4.58K 0.08% 105
2021
Q3
$1.45M Hold
3,012
– – 0.09% 91
2021
Q2
$1.48M Sell
3,012
-67
-2% -$33K 0.08% 91
2021
Q1
$1.47M Buy
3,079
+16
+0.5% +$7.3K 0.09% 79
2020
Q4
$1.29M Buy
3,063
+15
+0.5% +$5.78K 0.09% 84
2020
Q3
$1.03M Buy
3,048
+159
+6% +$54.3K 0.08% 98
2020
Q2
$938K Sell
2,889
-48
-2% -$14.6K 0.09% 86
2020
Q1
$772K Sell
2,937
-181
-6% -$61.4K 0.08% 93
2019
Q4
$1.17M Hold
3,118
– – 0.11% 83
2019
Q3
$1.1M Sell
3,118
-1,879
-38% -$658K 0.1% 100
2019
Q2
$1.77M Buy
4,997
+174
+4% +$60.8K 0.15% 81
2019
Q1
$1.66M Sell
4,823
-27
-0.6% -$9.08K 0.14% 84
2018
Q4
$1.47M Buy
4,850
+27
+0.6% +$8.99K 0.11% 94
2018
Q3
$1.77M Sell
4,823
-49
-1% -$17.9K 0.15% 86
2018
Q2
$1.73M Buy
4,872
+4,170
+594% +$1.47M 0.15% 86
2018
Q1
$240K Buy
+702
New +$244K 0.02% 215

Other funds holding MDY

Aspiriant LLC's MDY Position: Q3 2026 in Review

Aspiriant LLC reduced its State Street SPDR S&P MIDCAP 400 ETF Trust (MDY) stake by 0.88% in Q3 2026, selling an estimated $18.6K and leaving 3,036 shares worth $1.99M. The position accounts for 0.05% of the portfolio, ranked #117.

Aspiriant LLC first reported a position in MDY in Q1 2018 and has held it in 35 quarters since. The position peaked at $2.15M in Q2 2026. 978 funds tracked by Wall St. Rank hold MDY as of Q3 2026.

  • Aspiriant LLC held 3,036 shares of State Street SPDR S&P MIDCAP 400 ETF Trust worth $1.99M as of Q3 2026.
  • Aspiriant LLC sold 27 State Street SPDR S&P MIDCAP 400 ETF Trust shares in Q3 2026, an estimated $18.6K.
  • State Street SPDR S&P MIDCAP 400 ETF Trust made up 0.05% of Aspiriant LLC's portfolio in Q3 2026, its #117 holding.
  • Aspiriant LLC first reported a position in State Street SPDR S&P MIDCAP 400 ETF Trust in Q1 2018 and has held it in 35 quarters since.
  • Aspiriant LLC's State Street SPDR S&P MIDCAP 400 ETF Trust position peaked at $2.15M in Q2 2026.
  • 978 funds tracked by Wall St. Rank held State Street SPDR S&P MIDCAP 400 ETF Trust as of Q3 2026.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.